Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Asenapine

Asenapine

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Asenapine

17 trials tracked of Asenapine: 17 in phase 3 or 4 and 1 with published results. The most-cited published study has 89 citations.

17Trials tracked
17Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 15
  1. Phase 3 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017) Completed · 89 cited
  2. Phase 4 Asenapine in the Treatment of Older Adults With Bipolar Disorder Completed
  3. Phase 4 Treating Acutely Agitated Patients With Asenapine Sublingual Tablets Completed
  4. Phase 3 A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) Completed
  5. Phase 3 Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898) Completed
  6. Phase 3 Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771) Completed
Show 11 more trials
  1. Phase 3 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) Completed
  2. Phase 3 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786) Completed
  3. Phase 3 Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107) Completed
  4. Phase 3 Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238) Completed
  5. Phase 3 Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) Completed
  6. Phase 3 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777) Completed
  7. Phase 3 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) Completed
  8. Phase 3 Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717) Completed
  9. Phase 3 Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) Completed
  10. Phase 3 Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897) Completed
  11. Phase 3 Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691) Completed

Showing the 17 most-cited and recently-updated of 17 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.